Pregnancy: Teratogenic effects: LUMIQUIN cream contains the teratogen, Tretinoin, which may cause embryo-fetal death, altered fetal growth,
congenital malformations, and potential neurologic deficits. There are no adequate and well controlled studies in pregnant women.
LUMIQUIN cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.